Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Altimmune stock

Learn how to easily invest in Altimmune stock.

Altimmune Inc is a biotechnology business based in the US. Altimmune shares (ALT) are listed on the NASDAQ and all prices are listed in US Dollars. Altimmune employs 43 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Altimmune

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ALT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Altimmune stock price (NASDAQ: ALT)

Use our graph to track the performance of ALT stocks over time.

Altimmune shares at a glance

Information last updated 2022-01-16.
Latest market close$7.84
52-week range$7.35 - $24.61
50-day moving average $9.64
200-day moving average $11.95
Wall St. target price$31.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.11

Buy Altimmune shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Altimmune stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Altimmune price performance over time

Historical closes compared with the close of $7.84 from 2022-01-14

1 week (2022-01-10) -4.04%
1 month (2021-12-17) -16.24%
3 months (2021-10-15) -34.72%
6 months (2021-07-17) -16.06%
1 year (2021-01-15) -39.37%
2 years (2020-01-17) 326.09%
3 years (2019-01-17) 152.90%
5 years (2017-01-17) 33.5

Altimmune financials

Revenue TTM $3.4 million
Gross profit TTM $-25,324,291
Return on assets TTM -21.31%
Return on equity TTM -40.99%
Profit margin 0%
Book value $5.28
Market capitalisation $311.6 million

TTM: trailing 12 months

Altimmune share dividends

We're not expecting Altimmune to pay a dividend over the next 12 months.

Have Altimmune's shares ever split?

Altimmune's shares were split on a 1:30 basis on 13 September 2018. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Altimmune shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Altimmune shares which in turn could have impacted Altimmune's share price.

Altimmune share price volatility

Over the last 12 months, Altimmune's shares have ranged in value from as little as $7.35 up to $24.61. A popular way to gauge a stock's volatility is its "beta".

ALT.US volatility(beta: 1.36)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Altimmune's is 1.3573. This would suggest that Altimmune's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Altimmune overview

Altimmune, Inc. , a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company develops T-COVID, an intranasal immune modulating therapeutic candidate, which is in Phase 1/2 clinical trials to prevent clinical worsening in patients with early COVID-19; NasoShield, an anthrax vaccine product candidate that is in a Phase 1b trial; and NasoVAX, a recombinant intranasal vaccine product candidate for seasonal and pandemic use. It also focuses on developing pemvidutide, a next generation peptide therapeutics for non-alcoholic steatohepatitis; and HepTcell, an immunotherapeutic product candidate that is in Phase 2 studies for patients chronically infected with the hepatitis B virus. The company is headquartered in Gaithersburg, Maryland. .

Frequently asked questions

What percentage of Altimmune is owned by insiders or institutions?
Currently 5.923% of Altimmune shares are held by insiders and 84.844% by institutions.
How many people work for Altimmune?
Latest data suggests 43 work at Altimmune.
When does the fiscal year end for Altimmune?
Altimmune's fiscal year ends in December.
Where is Altimmune based?
Altimmune's address is: 910 Clopper Road, Gaithersburg, MD, United States, 20878
What is Altimmune's ISIN number?
Altimmune's international securities identification number is: US02155H2004
What is Altimmune's CUSIP number?
Altimmune's Committee on Uniform Securities Identification Procedures number is: 02155H101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site